Kirsten Harvey

7PUBLICATIONS
22CO-AUTHORS
Molecular targetsPredictive and prognostic markersNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Apr 25, 2025
Lysosomal TPC2 channels disrupt Ca2+ entry and dopaminergic function in models of LRRK2-Parkinson's disease.

Martina Gregori, Gustavo J S Pereira, Robert Allen

|Dec 23, 2019
LRRK2 Biology from structure to dysfunction: research progresses, but the themes remain the same.

Daniel C Berwick, George R Heaton, Sonia Azeggagh

|May 16, 2019
LRRK2, alpha-synuclein, and tau: partners in crime or unfortunate bystanders?

Tiago Fleming Outeiro, Kirsten Harvey, Antonio Dominguez-Meijide

|Dec 23, 2018
The role of LRRK2 in cell signalling.

Kirsten Harvey, Tiago F Outeiro

|Jan 21, 2017
Pathogenic LRRK2 variants are gain-of-function mutations that enhance LRRK2-mediated repression of β-catenin signaling.

Daniel C Berwick, Behzad Javaheri, Andrea Wetzel

Pageof 2